Reply to Roderick C.N. van den Bergh, Olivier Rouvière, and Theodorus van der Kwast's letter to the editor re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine use of magnetic resonance imaging for early detection of prostate cancer is not justified by the clinical trial evidence. Eur Urol 2020;78:304–6. Prebiopsy MRI: Through the looking glass Correspondence

  

Authors:	Vickers, A.; Carlsson, S. V.; Cooperberg, M.
Title:	Reply to Roderick C.N. van den Bergh, Olivier Rouvière, and Theodorus van der Kwast's letter to the editor re: Andrew Vickers, Sigrid V. Carlsson, Matthew Cooperberg. Routine use of magnetic resonance imaging for early detection of prostate cancer is not justified by the clinical trial evidence. Eur Urol 2020;78:304–6. Prebiopsy MRI: Through the looking glass
Keywords:	cancer patient; nuclear magnetic resonance imaging; prostate specific antigen; editorial; practice guideline; tumor biopsy; cancer mortality; prostate cancer; national health organization; predictive value; urologist; human; male; priority journal; early cancer diagnosis
Journal Title:	European Urology
Volume:	78
Issue:	3
ISSN:	0302-2838
Publisher:	Elsevier Science, Inc.
Date Published:	2020-09-01
Start Page:	314
End Page:	315
Language:	English
DOI:	10.1016/j.eururo.2020.06.059
PUBMED:	32631742
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85087977685&doi=10.1016%2fj.eururo.2020.06.059&partnerID=40&md5=d379dbe0a4e07ffb481c8d2f17ae8f96
Notes:	Editorial -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/169946